ArticleExperimental & molecular medicine2026
Isoform-specific roles of QKI-6 and QKI-7 direct Schwann cell lineage progression and enhance peripheral nerve regeneration.
Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuro-Instructive Hydrogels - A Key to Sensory Innervation in Oral Tissues: A Comprehensive Review.International journal of nanomedicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Peripheral nerve injury presents a major therapeutic challenge owing to limited endogenous repair and incomplete functional recovery. Schwann cells (SCs), the principal glia of the peripheral nervous system, support axonal integrity and regeneration, but the post-transcriptional mechanisms regulating their development and reparative function remain poorly defined. Here, we investigated the isoform-specific roles of the RNA-binding protein Quaking (QKI), which is alternatively spliced into nuclear (QKI-5) and cytoplasmic (QKI-6 and QKI-7) variants, in governing human Schwann lineage progression. Using a human pluripotent stem cell-derived Schwann cell precursor (SCP) platform, we found that QKI-6 and QKI-7 are selectively upregulated during SCP-to-SC transition, whereas QKI depletion disrupts SCP viability, differentiation, and splicing fidelity. Transcriptomic and rMATS analysis identified more than 800 QKI-dependent splicing events, including disease-relevant isoform shifts in PLP1 and PMP22. Isoform-specific rescue and gain-of-function assays revealed that QKI-6 supports SCP expansion and mitotic progression, whereas QKI-7 promotes SC maturation and neurotrophic output. In a mouse sciatic nerve transection model, transplantation of QKI-7-overexpressing SCPs or SCs significantly enhanced axonal regeneration, remyelination, and motor recovery compared with unmodified or QKI-6-expressing counterparts. Histological analysis confirmed improved donor cell engraftment, myelin protein expression, and neurotrophin levels in QKI-7-modified grafts. These findings establish a sequential, isoform-dependent mechanism of Schwann lineage control and nominate QKI-7 as a candidate for engineering reparative glial cells with enhanced regenerative capacity. Isoform-targeted modulation of RNA-binding proteins may represent a strategy to overcome intrinsic limitations in glial cell therapy for peripheral nerve disorders.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.